What is the recommended treatment for a hip arthritis flare-up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hip Arthritis Flare-Up

For hip arthritis flare-ups, NSAIDs at the lowest effective dose should be the first-line pharmacological treatment, combined with non-pharmacological approaches including rest, activity modification, and supportive devices. 1, 2

Step-by-Step Management Algorithm

First-Line Treatment

  1. Non-pharmacological interventions:

    • Rest and activity modification to avoid aggravating activities
    • Use of supportive devices (walking sticks, insoles) as needed
    • Weight reduction if overweight or obese
    • Structured exercise program (at least 3 times weekly for 30 minutes)
  2. Pharmacological treatment:

    • NSAIDs for 1-3 weeks:
      • Naproxen 500mg twice daily OR
      • Ibuprofen 400-800mg three to four times daily (total 1200-3200mg daily)
      • Use lowest effective dose for shortest duration
      • NSAIDs show significant pain relief with effect size of 0.69 (95% CI 0.12 to 1.26) and NNT of 4 (95% CI 3 to 6) 1, 2

Second-Line Treatment (if inadequate response to first-line)

  1. For patients with increased GI risk:

    • Non-selective NSAIDs plus gastroprotective agent OR
    • COX-2 selective inhibitor 1
  2. Alternative pharmacological options:

    • Paracetamol/Acetaminophen (up to 4g/day) for mild-moderate pain 1, 2
    • Opioid analgesics with or without paracetamol when NSAIDs are contraindicated, ineffective, or poorly tolerated 1

For Persistent Flare-Ups (unresponsive to above measures)

  • Intra-articular corticosteroid injection guided by ultrasound or x-ray 1, 2
    • Indicated when symptoms persist despite 2-3 weeks of conservative therapy
    • Effective with reported 80% resolution rate in some studies 2
    • Avoid multiple repeated injections due to potential tissue damage

Special Considerations and Precautions

NSAID Safety Concerns

  • Gastrointestinal risks: Higher in elderly, those with history of peptic ulcer, or concomitant use of corticosteroids or anticoagulants 3
  • Cardiovascular risks: Use with caution in patients with hypertension, heart failure, or history of cardiovascular disease 3
  • Renal risks: Monitor renal function in elderly patients and those with pre-existing renal disease 3

Medication Selection Based on Patient Factors

  • For elderly patients or those with comorbidities: Consider starting with lower doses of NSAIDs or using acetaminophen
  • For patients with severe pain: Higher doses of NSAIDs (e.g., ibuprofen 600-800mg TID/QID) may be more effective 4, 5
  • For patients with cardiovascular risk: Naproxen may have a slightly better cardiovascular safety profile than other NSAIDs 6

Long-term Management Considerations

  • Tailor treatment according to:

    • Hip risk factors (obesity, mechanical factors, physical activity, dysplasia)
    • General risk factors (age, sex, comorbidity, co-medication)
    • Pain intensity, disability level
    • Structural damage
    • Patient preferences 1
  • For patients with persistent symptoms despite optimal medical management, consider referral for surgical evaluation, particularly in younger adults with dysplasia or varus/valgus deformity 1

Remember that the goal of treatment is to reduce pain, improve function, and minimize medication-related adverse effects. The combination of non-pharmacological and pharmacological approaches provides the most effective management strategy for hip arthritis flare-ups.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hip Bursitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Review of ibuprofen for osteoarthritis.

The American journal of medicine, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.